UnitedHealth Group Incorporated (NYSE:UNH) Stake Boosted by Qsemble Capital Management LP

Qsemble Capital Management LP grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 161.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 8,414 shares of the healthcare conglomerate’s stock after purchasing an additional 5,194 shares during the quarter. UnitedHealth Group makes up 0.8% of Qsemble Capital Management LP’s portfolio, making the stock its 15th largest holding. Qsemble Capital Management LP’s holdings in UnitedHealth Group were worth $4,285,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently made changes to their positions in UNH. Norges Bank bought a new position in UnitedHealth Group in the 4th quarter worth approximately $5,802,231,000. Swedbank AB bought a new position in UnitedHealth Group in the 1st quarter worth approximately $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock worth $1,141,113,000 after buying an additional 1,196,758 shares in the last quarter. Baillie Gifford & Co. grew its holdings in UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after buying an additional 821,050 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado grew its holdings in UnitedHealth Group by 3,464.9% in the 4th quarter. Public Employees Retirement Association of Colorado now owns 825,311 shares of the healthcare conglomerate’s stock worth $434,501,000 after buying an additional 802,160 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 2,851 shares of the firm’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares of the company’s stock, valued at $16,812,029.88. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. The disclosure for this sale can be found here. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $589.75 on Thursday. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The business has a fifty day simple moving average of $564.99 and a 200 day simple moving average of $516.56. The firm has a market cap of $542.80 billion, a price-to-earnings ratio of 36.05, a P/E/G ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, topping the consensus estimate of $6.66 by $0.14. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the business posted $6.14 earnings per share. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.42%. The ex-dividend date is Monday, September 16th. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Ratings Changes

A number of brokerages have issued reports on UNH. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday. StockNews.com lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday. HSBC increased their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Robert W. Baird increased their price objective on UnitedHealth Group from $597.00 to $640.00 and gave the company an “outperform” rating in a research report on Wednesday, July 17th. Finally, Truist Financial increased their price objective on UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $614.17.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.